WHO - Repurposing medicines is the underrated champion of sustainable innovation in oncology - Anticancer Fund (with frame).jpg.png

WHO endorses drug repurposing strategy of the Anticancer Fund

First patient for EORTC-trial in oligometastatic rare cancers 

A publication by scientists of the Anticancer Fund

Trends in International Cancer Research Investment 2006-2018

Rachel Abudu, BS, MPH; Gauthier Bouche, MPH, MD; Karima Bourougaa, PhD; Lynne Davies, PhD; Kalina Duncan, BS, MPH; Carla Estaquio, PhD; Anna Diaz Font, PhD; Marc S. Hurlbert, PhD; Paul Jackson, PhD; Linda Kroeskop-Bossenbroek, PhD; Ian Lewis, PhD; Giota Mitrou, PhD; Abdul Mutabbir, BSc; Christopher A. Pettigrew, PhD; Lynn Turner, PhD; Annemarie Weerman, PhD; and Kari Wojtanik, PhD. Trends in International Cancer Research Investment 2006-2018. JCO Global Oncology, 2021 Apr;7:602-610. doi: 10.1200/GO.20.00591

Honorary association for Gauthier Bouche with University College London

Second step in trial for children with solid cancers

A publication by scientists of the Anticancer Fund

Repurposing Infectious Diseases Vaccines Against Cancer

Liese Vandeborne, Pan Pantziarka, An M. T. Van Nuffel and Gauthier Bouche. Repurposing Infectious Diseases Vaccines Against Cancer. Frontiers in Oncology, 13 May 2021, doi: 10.3389/fonc.2021.688755.
A publication by scientists of the Anticancer Fund

Exploring new uses for existing drugs: innovative mechanisms to fund independent clinical research

Ciska Verbaanderd, Ilse Rooman, Isabelle Huys. Exploring new uses for existing drugs: innovative mechanisms to fund independent clinical research. Trials, (2021) 22:322, doi:10.1186/s13063-021-05273-x

Diffuse intrinsic pontine glioma: a clinic in Mexico, social media, and unpublishable data

Gauthier Bouche, Eric Bouffet, Liese Vandeborne, Rica Capistrano, Nicolas André. Diffuse intrinsic pontine glioma: a clinic in Mexico, social media, and unpublishable data. The Lancet Oncology, Volume 22, Issue 5, P595-596, May 01, 2021, doi: 10.1016/S1470-2045(21)00009-7